Kathleen Harnden, MD MBA

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Pfizer
    Topic: 
    advisory board
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    SeaGen
    Topic: 
    physician speaker
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Merck
    Topic: 
    physician speaker
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Daiichi Sankyo
    Topic: 
    physician speaker
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Astrazeneca
    Topic: 
    physician speaker
    Date added: 
    10/25/2023
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/01/2023
Return to 2023 Inova Fairfax Medicine Grand Rounds (Enduring Material) 10.31.2023